Skip to main content

Jefferies Financial Group Inc.

Position in IBRX — ImmunityBio, Inc.

CIK 96223 NEW YORK, NY

Position in IBRX

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$2,301,000
+$2,253,600 QoQ
Shares Held
300,000
+3900.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IBRX Over Time

Shares Held

Position Value (USD)

Derivatives in IBRX

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$2,301,000
PutShares
300,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in IBRX

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,301,000 300,000
2026-03-31 $2,301,000 300,000
2024-06-30 $94,800 15,000
2024-06-30 $1,264,000 200,000
2024-06-30 $47,400 7,500
2023-03-31 $63,700 35,000
2023-03-31 $145,600 80,000